MS-MLPA Methylation Specific Multiplex Ligation Probe Amplification for detection of PWS/AS Oxford Somai Man/Kate Gibson MRC-Holland.

Slides:



Advertisements
Similar presentations
A review of the Wilson disease service over the past 15 years Miranda Durkie Sheffield Diagnostic Genetics Service
Advertisements

Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.
MRC-Holland b.v. Microdeletion in IC Copy no. Results 50% Microdeletion deleting exons 1-4 SNRPN Methylation Results 1.
Suggestions for PMS2 best practice Jenny Simmonds
Mohamad Ali Najia Summer Fellow, Bioinformatics and Integrative Genomics Program Harvard-MIT Division of Health Sciences and Technology Department of Cancer.
Differences from mendelian heredity Imprinting, dynamic mutations RNDr Z.Polívková Lecture No course: Heredity.
Fluorescence in situ Hybridization
Chris Campbell West Midlands Regional Genetics laboratory
HER-2 MLPA in patients with aberrant FISH patterns
Investigating the use of Multiple Displacement Amplification (MDA) to amplify nanogram quantities of DNA to use for downstream mutation screening by sequencing.
Detection of Genomic Rearrangements in K562 cells using Paired End Sequencing Rosa Maria Alvarez Massachusetts Institute of Technology Class of 2009.
Dawn M. Stults, Michael W. Killen Heather H. Pierce, Andrew J. Pierce Departments of Microbiology, Toxicology and Internal Medicine Markey Cancer Center,
Microarrays and Their Uses Brad Windle, Ph.D
Medical genetics Dr. Lina Basel Schneider Children’s Medical Center of Israel.
Chromosome Mutation Relocation of Genetic Material
EPIGENOMICS: DECIPHERING THE OTHER GENETIC CODE Sonia Guara Ciurana.
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: An Epigenetically Derived Monoclonal Origin for.
Patterns of genetic change in neuroblastomas
Genetic Profiling of MYCN non amplified Neuroblastoma by MLPA
Distribution of CpG dinucleotide in the human genome and differences in methylation patterns between normal and tumor cells. In the majority of the mammalian.
Frances Bond West Midlands Regional Genetics Laboratory 12/04/10
Gel electrophoresis analysis Automated DNA analyzer.
Fluorescence in situ hybridization (FISH). Figs
Imprinting-Mutation Mechanisms in Prader-Willi Syndrome
FIG. 5. Chromosome painting and G-banding analysis of mouse lymphoma Tk mutant 950 isolated from a bleomycin-treated culture (Clark et al., 2004). The.
Mutation Screening of EXT1 and EXT2 by Denaturing High-Performance Liquid Chromatography, Direct Sequencing Analysis, Fluorescence in Situ Hybridization,
876 fetal cord blood DNA samples
Mosaic Uniparental Disomies and Aneuploidies as Large Structural Variants of the Human Genome  Benjamín Rodríguez-Santiago, Núria Malats, Nathaniel Rothman,
Cardiac involvement in a female carrier of Duchenne muscular dystrophy
The Role of MGMT Testing in Clinical Practice
Peter John M.Phil, PhD Atta-ur-Rahman School of Applied Biosciences (ASAB) National University of Sciences & Technology (NUST)
Detection of Chromosome Aneuploidies in Chorionic Villus Samples by Multiplex Ligation-Dependent Probe Amplification  Angelique J.A. Kooper, Brigitte.
الاسبوع الإرشادي.
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity 
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma  Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh.
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification Enables a Rapid and Reliable Distinction between Male FMR1 Premutation and Full-Mutation.
Pitfalls of Multiple Ligation-Dependent Probe Amplifications in Detecting DMD Exon Deletions or Duplications  Man Jin Kim, Sung Im Cho, Jong-Hee Chae,
Multiplex Ligation-Dependent Probe Amplification
CSCI2950-C Lecture 3 September 13, 2007.
A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2  Jianli Li, Hongzheng Dai, Yanming Feng, Jia Tang, Stella Chen,
Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,
A DNA Microarray for the Detection of Point Mutations and Copy Number Variation Causing Familial Hypercholesterolemia in Europe  Marianne A. Stef, Lourdes.
Detecting 22q11.2 Deletions by Use of Multiplex Ligation-Dependent Probe Amplification on DNA from Neonatal Dried Blood Spot Samples  Karina M. Sørensen,
Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia  Anne Benard-Slagter,
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue  Marthe M. de Jonge, Dina Ruano, Ronald van Eijk, Nienke van der Stoep,
Molecular Pathology Curriculum for Medical Laboratory Scientists
T. Ohta, K. Buiting, H. Kokkonen, S. McCandless, S. Heeger, H
Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next- Generation Sequencing on a Four-Gene Panel  Ava Kwong, Vivian Y. Shin,
Multiplex Ligation-Dependent Probe Amplification Versus Multiprobe Fluorescence in Situ Hybridization To Detect Genomic Aberrations in Chronic Lymphocytic.
Figure Revised Niemann-Pick disease type C (NP-C) diagnostic algorithm for the use of biomarkers and genetic testing Revised Niemann-Pick disease type.
Development and Clinical Implementation of a Combination Deletion PCR and Multiplex Ligation-Dependent Probe Amplification Assay for Detecting Deletions.
S. Hussain Askree, Shika Dharamrup, Lawrence N. Hjelm, Bradford Coffee 
Figure 2 Flowchart for investigation and diagnosis of Beckwith– Wiedemann syndrome Figure 2 | Flowchart for investigation and diagnosis of Beckwith– Wiedemann.
Custom-Designed MLPA Using Multiple Short Synthetic Probes
Fine-Mapping Chromosomal Loss at 9p21: Correlation with Prognosis in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type  Nancy J. Senff, Willem.
Volume 11, Issue 19, Pages (October 2001)
A unique triadin exon deletion causing a null phenotype
A Novel Methylation PCR that Offers Standardized Determination of FMR1 Methylation and CGG Repeat Length without Southern Blot Analysis  Marina Grasso,
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer  Ramprasath Venkatachalam  Gastroenterology 
Spinal Muscular Atrophy
Nat. Rev. Endocrinol. doi: /nrendo
Association of In Vitro Fertilization with Beckwith-Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19  Michael R. DeBaun, Emily L. Niemitz,
Multiplex Ligation-Dependent Probe Amplification Identification of Whole Exon and Single Nucleotide Deletions in the CFTR Gene of Hispanic Individuals.
The MLPA assay and application to diagnosis of DGS
A Complex Rearrangement in the APC Gene Uncovered by Multiplex Ligation- Dependent Probe Amplification  Constanze Pagenstecher, Dorothea Gadzicki, Dietlinde.
Combined use of multiplex ligation-dependent probe amplification and automatic sequencing for identification of KAL1 defects in patients with Kallmann.
Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification 
DNA demethylation reactivates GSN expression in gastric cancer cells.
qPCR system for the FOXP3 TSDR to detect Treg.
Presentation transcript:

MS-MLPA Methylation Specific Multiplex Ligation Probe Amplification for detection of PWS/AS Oxford Somai Man/Kate Gibson MRC-Holland

Mechanisms causing PWS/AS Disease Mechanism PWS AS Large Deletion 70%  70% UPD  30% (mat)  5% (Pat) IC mutation 1% 5% Chromosome rearrangement <1% Other - ~10% UBE3A mutation ~ 10% Unknown Previously PWAS testing carried out by S blotting – this only detects aberrent methylation, so will distingiush between AS/PWS, but it will not confirm the mechanism of disease. Aberrant CpG island methylation-S.Blot, MS-MLPA

MS-MLPA (ME0028) MS-MLPA, detects changes in: COPY NO. (Standard MLPA) Differences in methylation status at Chr15q11-13. (HhaI) MS-MLPA can detect copy number variation and differences in methylation status, which means that the disease mechanism can be determined.

Mechanisms causing PWS/AS & effect seen using MS-MLPA kit Disease Mechanism PWS AS MS-MLPA Change Large Deletion 70%  70% Copy no. + Ch3n UPD  30% (mat)  5% (Pat) Ch3n IC mutation 1% 5% Chromosome rearrangement <1% - Other ~10% UBE3A mutation ~ 10% Unknown Large deletions show a copy number change along with aberrant methylation UPD/IC mutations show a normal copy number, but aberrant methylation. MS-MLPA cannot distinguish between UPD and IC mutations. NB: other methods cannot cannot discern between these

PWS/AS MS-MLPA Probe Mix Test probes: specific for sequences within & near 15q11-13; 5 contain a HhaI recognition site (SNRPN & NECDIN) Control probes: for copy number & HhaI digestion

Ligation & PCR as with standard MLPA MS-MLPA Procedure Overnight hybridisation Reaction split into 2 tubes Ligation & PCR as with standard MLPA Add HhaI, Ligate & PCR Overnight hybridisation occurs as normal, then each reaction is split in two, one for ligation as normal for the copy no test, the other for ligation and HhaI digestion for the methylation status. COPY NO. METHYLATION

HhaI HhaI cuts at unmethylated sites Only methylated (undigested) & ligated probes are exponentially amplified Methylated  signal Unmethylated  no signal

Understanding results-PWS Normal mUPD Doubling of Methylation dose m Ch3 Same (2) P IC m Ch3 Doubling of Methylation dose Same (2) Deletion (pat) m Ch3 P One methylation dose; like normal Reduced (1) Ch3 m P Expression Normal - Maternal allele is methylated, paternal unmethylated = copy no = 2, one methylation dose mUPD – Two copys of mat chr 15 present, both copies methylated, but two copies are present, IC – Mat/Pat alleles present, but IC mut causes aberrant methylation of pat allele = 2 copies but double methylation dose. Del – Reduced copy no, methylation dose is normal. One methylation dose Copy No: 2 NB: UPD and IC indistinguishable. Linked markers

Understanding results-AS Normal pUPD P No methylation signal Same (2) IC P m No methylation signal Same (2) Deletion (mat) m P No methylation signal Reduced (1) Ch3 m P Expression Normal - As previous slide mUPD – Two copys of pat chr 15 present, both copies unmathylated – no signal on MS-MLPA, but two copies are present, IC – Mat/Pat alleles present, but IC mut means that mat allele is unmethylated = 2 copies but no methylation signal Del – Reduced copy no, methylation signal is lost, as the methylated region of mat chr 15 is not present. One methylation dose Copy No: 2 NB: UPD and IC indistinguishable. Linked markers

Equal heights of probes in PWS/AS critical region = NO  Normal Results Copy no. Results 100% Control probes Now to show you some examples of results. Firstly typical results from a normal individual. And let’s consider the copy no. results first. The Y axis plots the copy number as a % figure and the X axis lists probes which map to different chromosomal regions. The blue + pink bars indicate copy number of control probes. The green bars indicate copy number of probes in order down chromosome 15q11-q13. The red dotted line indicates the normal level that should be present. Control probes (blue and pink) are the same height as the green test probes, indicating that there has not been any loss in copy number, i.e. no deletion. Chr15q11-13 probes: in order down csome 15q Control probes Equal heights of probes in PWS/AS critical region = NO 

Equal heights of probes in PWS/AS critical region = NO  Normal Results Copy no. Results Methylation Results 100% 0.5 Undigested Controls 1 Differentially Ch3td alleles 0.5 Digested Controls 0 Control probes Normal reults, copy number on left, methylation results right Dosage – Control probes in blue and red, critical region probes in green. All probes show at the same relative height – shown by the red 100% line therefore normal copy no. Methylation results. The green bars are our digest control probes. These should not be digested and always be present at the 100% level. The red arrows indicate digest control probes: these should ideally be completely digested. The white bars are the important ones to focus on. These are the differentially methylated probes and should show a half height pattern: representing maternal methylated alleles and unmethylated paternal alleles. Chr15q11-13 probes: in order down csome 15q Control probes Equal heights of probes in PWS/AS critical region = NO 

Understanding Results Deletions: 50% drop in relative peak height. Stats-cfn betwn patient & normal controls Methyln abnormalities: difference in dose of methyld allele Simple pairwise cfn betwn cut & uncut results from same patient Irrespective of mutation mechanism, methyln ratio for PWS= 1.0, AS= 0 Deletions show as an approximate 50% drop in relative peak height, when compared to control probes and normal control samples. Methylation abnormalities are calculated by a pairwise comparison between the cut and uncut results from the same patient. This means that although a PWS deletion is normally methylated, it always gives a methylation ratio of 1 because there is no second allele to compare itself to. AS always gives a methylation ratio of 0. Both results  conclusive diagnosis

Deletion Results PWS  AS  Copy no. Results Methylation Results 50% Half heights of probes in PWS/ AS Critical region =  Methylation Results What results may we get from deletion patients then? The left of the slide summarises results from a PWS patient and the right results from an AS  patient. Looking at the top row, you can see that the green probes, i.e. probes mapping into the 15q11q-13 region show half heights, indicating that there is a . The origin of this  can be deduced looking at the methylation data below. In cases of a paternal  causing PWS, only maternal alleles are present and these are fully methylated (represneted by the white bars in the bottom left chart) In cases of a maternal  causing AS, only paternal alleles are present and these are unmethylated (no white bars) 0.5 Doubling of methylation signal Loss of methylation signal

UPD/ IC Results PWS UPD/ IC AS UPD/ IC Copy no. Results 100% Equal heights of probes in PWS/ AS Critical region = NO  Methylation Results This slide summarises typical from IC/ UPD cases. Again, The left of the slide summarises results from a PWS patient and the right, results from an AS patient. The copy no. results indicate that there has been no , with all probe bars showing equal heights. However, the methylation data is abnormal. In PWS cases, the effective doubling in methylation dose indicates that there are 2 copies of maternal (methylated) alleles (caused by UPD or an IC mutation). In AS cases, the methylation signal disappears indicative of there being 2 copies of paternal (unmethylated) alleles (caused by UPD or an IC mutation). 0.5 Doubling of methylation signal Loss of methylation signal